This week on Contemporary OB/GYN: January 2 to January 6

Early pregnancy complications after frozen-thawed embryo transfer

Women who underwent a frozen-thawed embryo transfer (FET) for assisted reproductive technology (ART) treatment were nearly twice as likely to experience bleeding or miscarriage in the first trimester with hormone replacement cycles (HRC-FET) compared to natural cycles (NC-FET), according to a retrospective cohort study published in the European Journal of Obstetrics & Gynecology and Reproductive Biology.

A fresh start

As the holiday season leaves as quickly as it arrived, we are left with a clean slate for the year. This fresh opportunity promises a mountain of possibilities; however, the New Year can also be intimidating. From the challenge of getting back into the swing of things post holiday to determining what your goals will be for the year, many things can make the beginning of the New Year daunting.

Frequency of condomless sex among women using reversible methods of contraception

A substudy of the Evidence for Contraceptive Options and HIV Outcomes (ECHO) trial, which compared three highly effective, reversible methods of contraception, concluded that women assigned either a copper intrauterine device (Cu-IUD) or the levonorgestrel (LNG) implant may have had condomless sex more frequently than women assigned to intramuscular depo-medroxyprogesterone acetate (DMPA-IM).

Chromosomal abnormalities do not impact ART outcomes

Chromosomal abnormalities in infertile couples who use assisted reproductive technology (ART) do not appear to impact cumulative clinical pregnancy or live-birth rates, according to a study published in the Annals of Medicine. Although clinicians should offer preimplantation genetic testing (PGT) to prospective parents with chromosomal rearrangements, authors add, no evidence supports its universal use in this population.

Check back soon for additional updates!